DE602005007002D1 - Substituierte 4-alkyl- und 4-alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten - Google Patents
Substituierte 4-alkyl- und 4-alkanoylpiperidinderivate und deren verwendung als neurokininantagonistenInfo
- Publication number
- DE602005007002D1 DE602005007002D1 DE602005007002T DE602005007002T DE602005007002D1 DE 602005007002 D1 DE602005007002 D1 DE 602005007002D1 DE 602005007002 T DE602005007002 T DE 602005007002T DE 602005007002 T DE602005007002 T DE 602005007002T DE 602005007002 D1 DE602005007002 D1 DE 602005007002D1
- Authority
- DE
- Germany
- Prior art keywords
- alkanoylpiperidine
- derivatives
- substituted
- alkyl
- neurokinin antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101467 | 2004-04-08 | ||
PCT/EP2005/051509 WO2005097774A1 (en) | 2004-04-08 | 2005-04-04 | Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005007002D1 true DE602005007002D1 (de) | 2008-07-03 |
Family
ID=34928945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005007002T Active DE602005007002D1 (de) | 2004-04-08 | 2005-04-04 | Substituierte 4-alkyl- und 4-alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten |
Country Status (23)
Country | Link |
---|---|
US (1) | US20070213346A1 (de) |
EP (1) | EP1737838B1 (de) |
JP (1) | JP2007532516A (de) |
KR (1) | KR20070007347A (de) |
CN (1) | CN1938291B (de) |
AR (1) | AR048532A1 (de) |
AT (1) | ATE396185T1 (de) |
AU (1) | AU2005231986B2 (de) |
BR (1) | BRPI0509720A (de) |
CA (1) | CA2561967A1 (de) |
DE (1) | DE602005007002D1 (de) |
EA (1) | EA010312B1 (de) |
ES (1) | ES2307169T3 (de) |
IL (1) | IL178461A0 (de) |
JO (1) | JO2525B1 (de) |
MX (1) | MXPA06011683A (de) |
MY (1) | MY142773A (de) |
NO (1) | NO20065022L (de) |
NZ (1) | NZ550098A (de) |
PA (1) | PA8628901A1 (de) |
TW (1) | TWI358298B (de) |
WO (1) | WO2005097774A1 (de) |
ZA (1) | ZA200608356B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2598651A1 (en) * | 2005-02-23 | 2006-08-31 | Schering Corporation | Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
AU2010234087B2 (en) * | 2009-04-02 | 2016-05-12 | Merck Patent Gmbh | Piperidine and piperazine derivatives as autotaxin inhibitors |
US8895551B2 (en) | 2009-04-02 | 2014-11-25 | Shionogi & Co., Ltd. | Acrylamide compounds and the use thereof |
EP2493871B1 (de) * | 2009-10-30 | 2014-09-03 | Domain Therapeutics | Neuartige Oximderivate und deren Verwendung als allosterische Modulatoren von metabotropen Glutamatrezeptoren |
CA2917628A1 (en) * | 2013-09-12 | 2015-03-19 | F. Hoffmann-La Roche Ag | Indol-carboxamide derivatives |
EP3574907B1 (de) * | 2015-05-18 | 2023-08-23 | KaNDy Therapeutics Limited | Ein nk1/nk3-rezeptorantagonist zur behandlung von geschlechtshormonabhängigen erkrankungen |
AU2019233606A1 (en) | 2018-03-14 | 2020-09-17 | KaNDy Therapeutics Limited | Novel pharmaceutical formulation comprising dual NK-1/NK-3 receptor antagonists |
EP3983340B1 (de) * | 2019-06-12 | 2023-08-02 | Nouryon Chemicals International B.V. | Verfahren zur isolierung von carbonsäure aus einem wässrigen seitenstrom |
ES2963382T3 (es) | 2019-06-12 | 2024-03-26 | Nouryon Chemicals Int Bv | Proceso para la producción de peróxidos de diacilo |
ES2963357T3 (es) | 2019-06-12 | 2024-03-26 | Nouryon Chemicals Int Bv | Proceso para la producción de peróxidos de diacilo |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ321575A (en) * | 1995-10-30 | 1999-05-28 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives |
TW382017B (en) * | 1995-12-27 | 2000-02-11 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
GB0025354D0 (en) * | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
US6642226B2 (en) * | 2001-02-06 | 2003-11-04 | Hoffman-La Roche Inc. | Substituted phenyl-piperidine methanone compounds |
AU2003298369B2 (en) * | 2002-12-23 | 2009-08-27 | Janssen Pharmaceutica N.V. | Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
-
2005
- 2005-03-22 JO JO200534A patent/JO2525B1/en active
- 2005-04-04 DE DE602005007002T patent/DE602005007002D1/de active Active
- 2005-04-04 EA EA200601880A patent/EA010312B1/ru not_active IP Right Cessation
- 2005-04-04 CA CA002561967A patent/CA2561967A1/en not_active Abandoned
- 2005-04-04 JP JP2007506775A patent/JP2007532516A/ja not_active Ceased
- 2005-04-04 WO PCT/EP2005/051509 patent/WO2005097774A1/en active IP Right Grant
- 2005-04-04 CN CN2005800108231A patent/CN1938291B/zh not_active Expired - Fee Related
- 2005-04-04 NZ NZ550098A patent/NZ550098A/en unknown
- 2005-04-04 US US11/547,868 patent/US20070213346A1/en not_active Abandoned
- 2005-04-04 ES ES05729797T patent/ES2307169T3/es active Active
- 2005-04-04 EP EP05729797A patent/EP1737838B1/de active Active
- 2005-04-04 KR KR1020067021935A patent/KR20070007347A/ko not_active Application Discontinuation
- 2005-04-04 AU AU2005231986A patent/AU2005231986B2/en not_active Ceased
- 2005-04-04 AT AT05729797T patent/ATE396185T1/de active
- 2005-04-04 BR BRPI0509720-7A patent/BRPI0509720A/pt not_active IP Right Cessation
- 2005-04-04 MX MXPA06011683A patent/MXPA06011683A/es active IP Right Grant
- 2005-04-05 PA PA20058628901A patent/PA8628901A1/es unknown
- 2005-04-06 MY MYPI20051549A patent/MY142773A/en unknown
- 2005-04-07 TW TW094110941A patent/TWI358298B/zh not_active IP Right Cessation
- 2005-04-07 AR ARP050101376A patent/AR048532A1/es not_active Application Discontinuation
-
2006
- 2006-10-05 IL IL178461A patent/IL178461A0/en unknown
- 2006-10-06 ZA ZA200608356A patent/ZA200608356B/en unknown
- 2006-11-03 NO NO20065022A patent/NO20065022L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2005231986B2 (en) | 2011-02-24 |
EP1737838B1 (de) | 2008-05-21 |
EP1737838A1 (de) | 2007-01-03 |
AR048532A1 (es) | 2006-05-03 |
AU2005231986A1 (en) | 2005-10-20 |
TW200603797A (en) | 2006-02-01 |
BRPI0509720A (pt) | 2007-09-25 |
NZ550098A (en) | 2009-10-30 |
JO2525B1 (en) | 2010-03-17 |
JP2007532516A (ja) | 2007-11-15 |
EA200601880A1 (ru) | 2007-02-27 |
IL178461A0 (en) | 2007-02-11 |
ES2307169T3 (es) | 2008-11-16 |
CA2561967A1 (en) | 2005-10-20 |
TWI358298B (en) | 2012-02-21 |
ATE396185T1 (de) | 2008-06-15 |
EA010312B1 (ru) | 2008-08-29 |
CN1938291A (zh) | 2007-03-28 |
KR20070007347A (ko) | 2007-01-15 |
US20070213346A1 (en) | 2007-09-13 |
MXPA06011683A (es) | 2006-12-14 |
MY142773A (en) | 2010-12-31 |
NO20065022L (no) | 2006-11-03 |
ZA200608356B (en) | 2008-07-30 |
PA8628901A1 (es) | 2006-09-08 |
WO2005097774A1 (en) | 2005-10-20 |
CN1938291B (zh) | 2011-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005007002D1 (de) | Substituierte 4-alkyl- und 4-alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten | |
DE602005011593D1 (de) | Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten | |
ATE378338T1 (de) | Pyrrolopyridinderivate und deren verwendung als crth2-antagonisten | |
DE602005023639D1 (de) | Chinuclidinderivate und deren verwendung als muscarin-m3-rezeptor-antagonisten | |
ATE446953T1 (de) | P2x7-rezeptorantagonisten und deren verwendung | |
ATE471938T1 (de) | Substituierte diazaspiroä4.5üdecanderivate und deren verwendung als neurokininantagonisten | |
DE60325493D1 (de) | Substituierte 1,4-dipiperidin-4-yl-piperazinderivate und deren verwendung als neurokininantagonisten | |
DE60336266D1 (de) | Substituierte 1-piperidin-4-yl-pyrrolidin-3-yl-piperazinderivate und deren verwendung als neurokinin antagonisten | |
DE602005004144D1 (de) | Octahydropyrroloä3,4-cüpyrrolderivate und deren verwendung als antivirale mitteln | |
DE602004021037D1 (de) | Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren | |
ATE511507T1 (de) | Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten | |
ATE426597T1 (de) | Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel | |
ATE472546T1 (de) | 5-heteroarylthiazole und deren verwendung als pi3k-inhibitoren | |
DE602005001123D1 (de) | Wässrige Emulsion und deren Verwendung | |
ATE409182T1 (de) | Tetrahydrochinolinone und deren verwendung als antagonisten von metabotropen glutamatrezeptoren | |
ATE395339T1 (de) | Biphenylderivate und deren verwendung als fungizide | |
ATE428710T1 (de) | Substituierte phenylaminothiazole und ihre verwendung | |
DE602005009988D1 (de) | Härtbare Zusammensetzung und deren Verwendung | |
DE602005022060D1 (de) | Diaminoalkohole und deren verwendung als renininhibitoren | |
ATE517098T1 (de) | Acylaminothiazolderivate und deren verwendung als beta-amyloid-inhibitoren | |
FI20060188A (fi) | Modifioidut IL-4-muteiinin reseptorin antagonistit | |
ATE542806T1 (de) | Diarylmethylpiperazinderivate, deren herstellung und deren verwendung | |
ATE551329T1 (de) | Chinazolinonderivate und deren verwendung als cb- agonisten | |
DE602004022458D1 (de) | Pyrazolderivate und ihre verwendung als orexin-rezeptor-antagonisten | |
DE602004028700D1 (de) | Kosmetische Zusammensetzungen und deren Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |